MGMA statement on final 2025 Medicare Physician Fee Schedule (November 1, 2024)

FOR IMMEDIATE RELEASE:
November 1, 2024

Media Contact:
Emily Dowsett
Director, Policy Communications
edowsett@mgma.com
 

MGMA statement on final 2025 Medicare Physician Fee Schedule

Anders Gilberg
Senior Vice President, Government Affairs
Medical Group Management Association

“CMS and Congress have once again overlooked the sobering financial realities facing our nation's medical practices, finalizing a 2.83% reduction to the 2025 Medicare conversion factor, further increasing the gap between practice expenses and reimbursement rates. Today's final rule throws the financial viability of physician practices into question and threatens beneficiary access to care. On a positive note, we are pleased CMS heeded our call to finalize numerous telehealth policies, such as permanently covering audio-only services and extending flexibilities for direct supervision and home address reporting for practitioners. Congress must immediately return from recess to pass H.R. 10073, averting the 2025 cut to the conversion factor and stabilizing physician practices until a more permanent, sustainable solution to the Medicare physician payment system can be realized.”

###

About MGMA

Founded in 1926, the Medical Group Management Association (MGMA) is the nation's largest association focused on the business of medical practice management. MGMA consists of 15,000 group medical practices ranging from small private medical practices to large national health systems representing more than 350,000 physicians. MGMA helps nearly 60,000 medical practice leaders and the healthcare community solve the business challenges of running practices so that they can focus on providing outstanding patient care. Specifically, MGMA helps its members innovate and improve profitability and financial sustainability, and it provides the gold standard on industry benchmarks such as physician compensation. The association also advocates extensively on its members' behalf on national regulatory and policy issues.